Overview of the role of liquid biopsy in cancer management
With the emergence of novel targeted therapeutic options in early-stage and advanced-stage malignancies, researchers have shifted their focus on developing personalized treatment plans through molecular profiling. Circulating tumor DNA (ctDNA) is a cell-free DNA (ctDNA) fragment, originating from tu...
Main Authors: | Tarek Assi, Rita Khoury, Rebecca Ibrahim, Maria Baz, Tony Ibrahim, Axel LE Cesne |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523323000888 |
Similar Items
-
The Liquid Biopsy in the Management of Colorectal Cancer: An Overview
by: Marco Vacante, et al.
Published: (2020-08-01) -
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
by: Sabrina Weber, et al.
Published: (2020-06-01) -
The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
by: Aleksandra Bożyk, et al.
Published: (2022-10-01) -
The Role of Liquid Biopsy Analytes in Diagnosis, Treatment and Prognosis of Colorectal Cancer
by: JinHua He, et al.
Published: (2022-06-01) -
Liquid Biopsy in Gastrointestinal Cancers
by: Aman Saini, et al.
Published: (2018-10-01)